Bone marrow stromal cell (BMSC)-mediated endochondral bone formation may be a promising alternative to the current gold standards of autologous bone transplantation, in the development of novel methods for bone repair. Implantation of chondrogenically differentiated BMSCs leads to bone formation in vivo via endochondral ossification. The success of this bone formation in an allogeneic system depends upon the interaction between the implanted constructs and the host immune system. The current study investigated the effect of chondrogenically differentiated human bone marrow stromal cell 
Rosendahl, Zetterberg, & Ringden, 2003; Lohan et al., 2014; Ryan et al., 2014; Sudres et al., 2006) . It is unclear whether these immunomodulatory properties are maintained upon differentiation. Allogenic chondrogenically differentiated BMSCs could be used in a therapy as an alternative to the current gold standard for bone repair, autologous bone transplantation. For this to become a feasible option, the interaction between the implanted cells and the host immune system in the process of the bone formation needs to be fully elucidated.
Although there have been many studies investigating the effects of undifferentiated BMSCs on host immune cells, little is known about the effect of chondrogenically differentiated BMSC pellets. Undifferentiated BMSCs are known to have an immunosuppressive effect on T lymphocytes (Di Nicola et al., 2002; Krampera et al., 2003; Mougiakakos et al., 2011) . In a recent study by our group, direct coculture of chondrogenically differentiated BMSC pellets and peripheral blood mononuclear cells (PBMCs) revealed that chondrogenically differentiated BMSC pellets did not induce the proliferation of naïve or stimulated T lymphocytes, suggesting that allogeneic chondrogenically differentiated BMSC pellets are non-immunogenic (Kiernan et al., 2016 ). However, it is possible that there might be an indirect stimulation of T cells by dendritic cells (DCs) that have encountered these BMSCs. DCs are the main antigen-presenting cells (APCs) of the innate immune system, with a primary role in activating T-cell-dependent immune responses (Guermonprez, Valladeau, Zitvogel, Thery, & Amigorena, 2002) . Therefore, the aim of the current research was to determine if chondrogenically differentiated BMSC pellets affect DCs.
Immature DCs survey the peripheral tissues for potential threats to the immune system, have low levels of major histocompatibility complex (MHC) molecules (or human leukocyte antigen [HLA] ) and the costimulatory molecules CD80 and CD86, and are not yet equipped to stimulate naïve T cells. Antigen uptake and processing by immature DCs, in addition to locally produced inflammatory cytokines, induce their maturation and migration to the draining lymph nodes. DC maturation is a prerequisite for the stimulation of naïve and memory T cells (Lutz & Schuler, 2002) . Therefore, DCs present themselves as potential targets for BMSC-mediated immunosuppression. Undifferentiated BMSCs have been shown to inhibit the differentiation, maturation, and function of DCs (Jiang et al., 2005; Spaggiari, Abdelrazik, Becchetti, & Moretta, 2009; Zhang et al., 2004) , however, little is known about the effect of chondrogenically differentiated BMSCs on DCs. Chondrogenically differentiated BMSCs have been reported to be more immunogenic compared with undifferentiated BMSCs (Chen et al., 2007; Ryan et al., 2014) . However, few studies have directly cocultured chondrogenically differentiated BMSC pellets and immune cells. Undifferentiated BMSCs lack immunogenicity due to the absence of MHC Class I or costimulatory molecule expression on their surface, and their ability to secrete immunosuppressive molecules (PGE2, NO and IDO; Chen, Tredget, Wu, & Wu, 2008; Meisel et al., 2004; Ryan, Barry, Murphy, & Mahon, 2007; Sato et al., 2007) . Chondrogenically differentiated BMSCs in contrast may lose this immunosuppressive capacity by upregulating costimulatory molecules on the surface, leading to induced DC maturation and enhanced lymphocyte proliferation (Chen et al., 2007) . In addition to this, the anti-inflammatory mediators PGE2 and NO have been shown to be significantly reduced upon chondrogenic differentiation of BMSCs, inducing immunogenicity in these cells . Contradictory to these reports, Zheng, Li, Ding, Jia, and Zhu (2008) Human bone marrow stromal cells (hBMSCs) were isolated as previously described (Kiernan et al., 2016 ) from heparinised femoral-shaft marrow aspirates of patients undergoing total hip arthroplasty (with informed consent after approval by Erasmus MC medical ethical committee protocol METC-2004-142) . hBMSCs were expanded in standard medium consisting of minimum essential medium alpha medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% heatinactivated fetal calf serum (Life Technologies; The Netherlands; lot number, 41Q2047K); 50-μg/ml gentamycin; 1.5-μg/ml fungizone (All Invitrogen); 1-ng/ml fibroblast growth factor-2 (Instruchemie B.V., Delfzijl, The Netherlands); and 0.1 mM of L -ascorbic acid 2-phosphate (Sigma-Aldrich, MO, USA). hBMSCs were cultured at 37°C under humidified condition and 5% carbon dioxide, refreshing medium every 3-4 days. Third to fourth passage cells were trypsinised using 0.05% trypsin (Life Technologies) when they reached 80-90% confluency and used for BMSC pellet cultures. hBMSCs (0.2 × 10 6 ) were added to 15-ml polypropylene tubes (Sarstedt) in 0.5 ml of standard chondrogenic medium consisting of high-glucose Dulbecco's modified
Eagle's medium with 50-mg/ml gentamicin; 1.5-mg/ml Fungizone (Invitrogen); 100-mM sodium pyruvate (Sigma-Aldrich); 1:100 ITS (BD Biosciences); L -ascorbic acid 2-phosphate; 10-ng/ml TGF-β3 (Peprotech);
and 100-nM dexamethasone (Sigma-Aldrich). Cells were cultured for 10 days with TGFβ3, refreshing the medium every 3-4 days.
| Generation and culture of monocyte-derived DCs
PBMCs were isolated from buffy coats of healthy male blood donors (Sanquin Bloedvoorziening, Rotterdam, The Netherlands), using previously described methods (Kiernan et al., 2016) . Briefly, peripheral blood was diluted 1:1 in wash medium (RPMI-1640 medium containing 1.5-μg/ml fungizone and 50-μg/ml gentamycin) and divided into 50-ml-filtered falcon tubes containing Ficoll-Paque PLUS (density 1.077 g/ml; GE Healthcare, Uppsala, Sweden) and centrifuged (690g no brake, 20 min). The plasma was carefully removed and discarded.
The remaining layers above the filter were transferred to a new 50-ml falcon tube and centrifuged at 835g for 7 min with brake. Following four washing steps (in wash medium, 690× g for 7 min), monocytes were separated from freshly obtained PBMCs using the MACS Mono- 2.4 | Phenotypic analysis of DC populations using flow cytometry 
| Analysis of DC phagocytic uptake
To study the effect of chondrogenically differentiated hBMSC pellets on DC phagocytic uptake capacity, 5 × 10 5 DCs were harvested and resuspended in 1 ml of PBS containing FITC-Dextran (1 mg/ml; Sigma). Cells were transferred back to the 24-well plates and incubated for 1 hr at 37°C, or at 4°C as a control. The DCs were then harvested; centrifuged (248g, 8 mins); and resuspended in ice-cold PBS.
Samples were washed twice with ice-cold PBS and resuspended in 500 μl of FACSflow. Quantitative uptake of FITC-Dextran was analysed by flow cytometry as above.
| Analysis of DC migratory capacity
Cell migration was performed using 24-well Transwell chambers 2.7 | IL-6, IL-10, and IL-12 secretion from supernatants from coculture
Supernatants from the cocultures were centrifuged at 690g for 10 min and stored at −80°C for later analysis. IL-6 (Peprotech), IL-10 (R&D Systems), and IL-12 (Peprotech) secretion was determined in the supernatants from the cocultures using enzyme-linked immunosorbent assay measurements. The measurements were performed and calculated according to manufacturer's instructions.
| Histological analysis of chondrogenic hBMSC pellets cultured with DCs
Chondrogenic hBMSC pellets cultured with and without DCs were harvested, washed in PBS, and then fixed in 4% formalin for 1 hr at room temperature. Following fixation, pellets were embedded in 3% agarose, processed, and embedded in paraffin. Sectioned slides were deparaffinised through alcohol series (xyleen, 100% ethanol, 96% ethanol, and 70% ethanol) and rinsed twice in distilled water. For thionine staining, sections were stained for 5 min with 0.04% thoinin in 0.01-M aqueous sodium acetate (pH 4.5) followed by differential staining in 70% ethanol (+/−10 s), 96% ethanol (+/− 30 s), and 100% ethanol
(1 min). For CD11c staining, antigen retrieval was first performed by heating samples to 80-90°C for 20 min in Dako heat antigen retrieval solution (S1699, Dako, Heverlee, Belgium). Nonspecific antibody binding was blocked using 1% milk block in 1% BSA in PBS solution.
Sectioned slides were stained using a rabbit monoclonal anti-CD11 (EP1347Y, Genetex) or rabbit IgG as a negative control antibody (X0903, Dako Cytomation) and labelled using an alkaline phosphatase link and label (Biogenex) to identify the presence of DCs within the matrix of the cells.
| Quantitative real-time reverse transcription polymerase chain reaction
Immature and LPS-matured DCs were removed from the coculture, washed with PBS, and resuspended in TRIzol reagent (Thermo Scientific). Similarly, chondrogenically differentiated hMSCs were removed from the coculture, washed with PBS, and crushed in TRIzol reagent.
RNA was isolated from all samples using RNeasy mini kit (Qiagen).
Complementary DNA was synthesised from isolated RNA using firststrand complementary DNA synthesis kit (Thermo Scientific) and used for real-time reverse transcription polymerase chain reaction (PCR).
Quantitative gene expression was determined using qPCR Mastermix Chondrogenically differentiated hBMSCs cultured in 3D for 10 days were added to immature or LPS-matured DCs for 24 hr ( Figure 1a) at a ratio of one BMSC to five DCs. Thionine staining performed on hBMSC pellets confirmed that they were chondrogenic ( Figure S1 ). Furthermore, the percentage of CD11c positive cells began to diminish after 72 hr in LPS-matured DCs ( Figure S3 ). These results demonstrate that chondrogenically differentiated hBMSC pellets do not induce DC maturation.
| Chondrogenically differentiated hBMSC pellets do not inhibit the antigen uptake capacity in immature DCs
Antigen 
| DISCUSSION
The immunomodulatory properties of undifferentiated hBMSCs have been widely studied (Aggarwal & Pittenger, 2005; Di Ianni et al., 2008; Di Nicola et al., 2002; Jiang et al., 2005; Roemeling-van Rhijn et al., 2013; Zhang et al., 2004) ; however, it is uncertain whether differentiated hBMSCs maintain these immunomodulatory properties.
Chondrogenically differentiated hBMSC pellets have been shown to form bone in both immunodeficient and immunocompetent animals (Farrell et al., 2011) . The use of allogeneic chondrogenically differentiated hBMSCs could provide a novel "off the shelf" treatment for the repair of bone defects; however, the role of the host cells in the process of the bone formation by allogeneic chondrogenic hBMSCs still needs to be established. Our group has previously shown that chondrogenically differentiated hBMSC pellets do not directly induce T cell responses following 7-day in vitro culture (Kiernan et al., 2016) . Due to the fact that DCs are the key players in stimulating T
FIGURE 4
Chondrogenically differentiated human bone marrow stromal cell (hBMSC) does not induce dendritic cell (DC) migration over time. Immature (black) and lipopolysaccharide (LPS)-matured (grey) DCs were harvested following 24, 48, and 72 hr of coculture with chondrogenically differentiated hBMSC pellets. The DCs from the coculture were seeded in the upper chamber of the transwell system, and CCL21 or control medium was placed in the lower chamber. DCs were incubated for 3 hr at 37°C. The cells that had migrated were harvested, and an equal amount of counting beads was added to the samples. Samples were analysed by flow cytometry, and the absolute cell count for each sample was calculated. hBMSCs (Jiang et al., 2005) . Chondrogenically differentiated hBMSC pellets again did not induce FITC-dextran uptake in immature DCs Allogeneic chondrogenic hBMSC pellets had no significant effect on LPS-matured DC antigen uptake or migratory capacity.
Interestingly, it appears from this study that IL-6 appears to play an important role in the interaction between allogeneic chondrogenic hBMSCs and DCs. IL-6 is a pleiotropic cytokine known to be essential in the development of APCs (Chomarat, Banchereau, Davoust, & Palucka, 2000; Xing et al., 1998) . It has been previously shown that IL-6 could be responsible for the ability of undifferentiated BMSCs to inhibit DC functions (Djouad et al., 2007; Jiang et al., 2005) . Following 24 hr of coculture, it was found that IL-6 was significantly secreted in supernatants from cultures of LPS-matured DCs and allogenic chondrogenic hBMSC pellets and this continued over 48 and 72 hr of coculture. At mRNA level, IL-6 expression was found to be significantly increased by allogeneic chondrogenic hBMSC pellets cultured with LPS-matured DCs demonstrating that the allogeneic chondrogenic hBMSCs were responsible for the production of the IL-6. It has been hypothesised that IL-6 secretion by undifferentiated BMSCs maintains the CD14 monocyte population as opposed to specifically inhibiting the DCs (Jiang et al., 2005) . However, all of the DCs were CD14 negative in coculture with chondrogenic hBMSC pellets.
Although there was no clear effect of allogeneic chondrogenic hBMSC pellets on maturation or function of LPS-matured DCs at 24 or 48 hr, IL-6 production appears to be produced by the pellets in response to LPS-matured DCs. It is possible that this was why there was no altered behaviour of the DCs. The secretion of IL-10 and IL-12 was also measured in the supernatants. IL-10 was not secreted by either immature DCs or immature DCs cocultured with allogeneic hBMSC pellets after 24 hr ( Figure S4 ). It was secreted by chondrogenically differentiated BMSC pellets cultured alone, LPS-matured DCs and LPS-matured DCs cocultured with chondrogenic hBMSC pellets. However, there was no significant difference in the secretion of IL-10 between cocultures. IL-12 is known to be involved in the differentiation and function of naïve T cells into effector cells (Hsieh et al., 1993) . IL-12 was found to be secreted in both immature and LPS-matured DCs cocultured with allogeneic chondrogenically differentiated hBMSCs for 24 hr.
However, there was no significant difference in IL-12 secretion between conditions. Over time, the level of IL-12 secretion was also measured in supernatants ( Figure S5 ). It was found that IL-12 was secreted at higher levels in supernatants from cocultured LPS-matured DCs and chondrogenic hBMSC pellets following 48 and 72 hr, although at a much lower concentration in comparison to IL-6. The secretion of both IL-6 and IL-12 might lead ultimately to the induction of specific T cell responses, or the balance between these cytokines might prevent T cell activation by DCs.
In conclusion, we show for the first time that allogeneic chondrogenic hBMSC pellets do not induce maturation of immature DCs in comparison with LPS-matured DCs. We did not observe strong immune responses from these DCs in coculture over time. Furthermore, they had no immunomodulatory effects on LPS-matured DCs;
however, IL-6 appears to be an important cytokine secreted by allogeneic chondrogenic hBMSC pellets in response to LPS-matured DCs.
Hall marks of DC activation are elevated levels of costimulatory molecules, reduced capacity for antigen uptake, migration and the production of cytokines. Here, we show that none of these characteristics (1 different hBMSC and DC donors in triplicate at 3 timepoints) ± SD Unpaired t-test *p < 0.05, **p < 0.005, ***p < 0.001 
